Rankings
▼
Calendar
CRON Q1 2023 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q1 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$19M
-31.3% YoY
Gross Profit
$3M
15.0% margin
Operating Income
-$21M
-106.5% margin
Net Income
-$19M
-98.3% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
-14.8%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$48M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$33M
Stockholders' Equity
$1.1B
Cash & Equivalents
$414M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19M
$28M
-31.3%
Gross Profit
$3M
$8M
-65.1%
Operating Income
-$21M
-$40M
+47.7%
Net Income
-$19M
-$41M
+53.0%
Revenue Segments
Cannabis Flower
$13M
65%
Cannabis Extracts
$7M
35%
Product and Service, Other
$66,000
0%
Geographic Segments
CANADA
$14M
72%
ISRAEL
$5M
25%
UNITED STATES
$649,000
3%
← FY 2023
All Quarters
Q2 2023 →